Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cilo Cybin HoldingsJSE:CCC 7 Current Ratio is 18.49 as of Sep. 2025, which is at its 10-year median of 18.49. GuruFocus rates JSE:CCC with a GF Score™ of 7/100. The stock has 1 warning sign investors should review. Among 1,000 Drug Manufacturers companies, Cilo Cybin Holdings ranks better than 97.4% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Cilo Cybin Holdings's current ratio for the quarter that ended in Sep. 2025 was 18.49.
Cilo Cybin Holdings has a current ratio of 18.49. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Cilo Cybin Holdings's Current Ratio or its related term are showing as below:
JSE:CCC'
s Current Ratio Range Over the Past 10 Years
Min: 0.12 Med: 18.49 Max: 77.47
Current: 18.49
During the past 4 years, Cilo Cybin Holdings's highest Current Ratio was 77.47. The lowest was 0.12. And the median was 18.49.
JSE:CCC's Current Ratio is ranked better than 97.4% of 1000
companies
in the Drug Manufacturers industry
Industry Median: 1.97
vs JSE:CCC: 18.49
Cilo Cybin Holdings (JSE:CCC) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Cilo Cybin Holdings Current Ratio Related Terms
Cilo Cybin Holdings Current Ratio Historical Data
* Premium members only.
The historical data trend for Cilo Cybin Holdings's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:CCC vs ZTS, UTHR, VTRS: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cilo Cybin Holdings Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Cilo Cybin Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cilo Cybin Holdings (JSE:CCC) has a Current Ratio of 18.49 as of Sep. 2025. This is near median its historical median of 18.49. Over the past decade, Cilo Cybin Holdings' Current Ratio has ranged from 0.12 to 77.47. According to the industry distribution chart, Cilo Cybin Holdings ranks #26 out of 1000 companies in the Drug Manufacturers industry, placing it in the top 2.6%.
Is Cilo Cybin Holdings' Current Ratio too high?
Cilo Cybin Holdings' current Current Ratio of 18.49 is near median its 10-year median of 18.49. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 77.47. The Drug Manufacturers industry median Current Ratio is 1.97. Cilo Cybin Holdings' value of 18.49 is 838.6% above this industry median. Based on the distribution chart, Cilo Cybin Holdings ranks #26 out of 1000 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cilo Cybin Holdings has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Cilo Cybin Holdings' Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cilo Cybin Holdings ranks #26 out of 1000 companies for Current Ratio. This places Cilo Cybin Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.97. Cilo Cybin Holdings' value of 18.49 is 838.6% above this benchmark. Historically, Cilo Cybin Holdings' own Current Ratio has ranged from 0.12 to 77.47 over the past decade. While the company's 10-year median is 18.49 vs. the industry median of 1.97, Cilo Cybin Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 1.97, based on 1,000 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cilo Cybin Holdings's current Current Ratio of 18.49 is 838.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cilo Cybin Holdings's current Current Ratio is 18.49, which is near median its own 10-year median of 18.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cilo Cybin Holdings stock overvalued right now?
Cilo Cybin Holdings (JSE:CCC) has a current Current Ratio of 18.49. The current Current Ratio is 18.49, which is near median its 10-year median of 18.49 and 838.6% above the Drug Manufacturers industry median of 1.97. Cilo Cybin Holdings' overall GF Score™ is 7/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Cilo Cybin Holdings (JSE:CCC), the current Current Ratio is 18.49 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cilo Cybin Holdings Ltd is engaged in identifying viable investments in Biotech, Biohacking and Pharmaceutical businesses. It offers products and services in the medical cannabis sector.
7GF Score
Get the complete analysis for JSE:CCC
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:CCC has been successfully added to your 
